S1 Episode 6: New and Emerging Therapies in H...

Drs Michael S. Saag and Charles W. Flexner discuss the mechanisms of drug-drug interactions and the promise and limitations of longer-acting HIV therapeutics for both treatment and prevention. Relevant disclosures can be found with the episode show notes on Medscape ( https://www. ...  Show more

Drs Michael S. Saag and Monica Gandhi discuss COVID-19 and the impact this pandemic has had on patients diagnosed with HIV, including vaccines, boosters, and patients who are older or have chronic comorbid conditions. Relevant disclosures can be found with the episode show notes ...  Show more

Drs. Anshel Kenkare and Mike Reid share a conversation about the incredible science and current context of lenacapavir for HIV prevention, which was recently approved by the FDA.Episodes | Consult Notes | Subscribe | Twitter | Merch | febrilepodcast@gmail.comFebrile is produced w ...  Show more

Join experts Drs Kevin Kalinsky and Aditya Bardia as they discuss utilizing antibody-drug conjugates in clinic. What is currently available? What are the possible side effects? Tune in to find out. Relevant disclosures can be found with the episode show notes on Medscape (https:/ ...  Show more

SGLT2 inhibitors, publishing choices, second and third order effects of interventions, decision support, and patient selection for preventive procedures are the topics John Mandrola, MD, discusses in this week's podcast.

This podcast is intended for healthcare profe ...

In this episode I cover HIV.

If you want to follow along with written notes on HIV go to https://zerotofinals.com/medicine/infectiousdisease/hiv/ or the infectious diseases section in the Zero to F ...